Sandoz International GmbH

About Sandoz International GmbH

Sandoz is a global leader in generic and biosimilar pharmaceuticals, operating as a division of Novartis. Headquartered in Holzkirchen, Germany, with its legal entity Sandoz International GmbH based in Switzerland, the company develops, manufactures, and markets affordable high-quality medicines across therapeutic areas such as cardiovascular, respiratory, oncology, immunology, and infectious diseases. Sandoz leverages Novartis’ research capabilities and its own extensive portfolio to provide cost-effective alternatives to branded drugs, serving patients, healthcare providers, and payers in over 140 countries. Its business model emphasizes innovation in complex generics and biosimilars, robust manufacturing, and strategic partnerships to expand access to essential medicines worldwide.